Department of Surgery, Center for Surgery, Innovation, & Bioengineering, Massachusetts General Hospital, Harvard Medical School and the Shriners Hospitals for Children, Boston, MA 02114, USA.
Department of Surgery, Center for Surgery, Innovation, & Bioengineering, Massachusetts General Hospital, Harvard Medical School and the Shriners Hospitals for Children, Boston, MA 02114, USA; Department of Biomedical Engineering, Rutgers University and the Department of Medicine, Rutgers Biomedical and Health Sciences, Piscataway, NJ 08854, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
Exp Cell Res. 2018 Jan 1;362(1):102-110. doi: 10.1016/j.yexcr.2017.11.007. Epub 2017 Nov 11.
Adult bone marrow mesenchymal stromal cells (MSCs) have cross-functional, intrinsic potency that is of therapeutic interest. Their ability to regenerate bone, fat, and cartilage, modulate the immune system, and nurture the growth and function of other bone marrow hematopoietic stem/progenitor cells have all been evaluated by transplant applications of MSCs. These applications require the isolation and expansion scaled cell production. To investigate biophysical properties of MSCs that can be feasibly utilized as predictors of bioactivity during biomanufacturing, we used a low-density seeding model to drive MSCs into proliferative stress and exhibit the hallmark characteristics of in vitro aging. A low-density seeding method was used to generate MSCs from passages 1-7 to simulate serial expansion of these cells to maximize yield from a single donor. MSCs were subjected to three bioactivity assays in parallel to ascertain whether patterns in MSC age, size, and shape were associated with the outcomes of the potency assays. MSC age was found to be a predictor of adipogenesis, while cell and nuclear shape was strongly associated to hematopoietic-supportive potency. Together, these data evaluate morphological changes associated with cell potency and highlight new strategies for purification or alternatives to assessing MSC quality.
成人骨髓间充质基质细胞(MSCs)具有跨功能的内在潜能,这引起了人们的治疗兴趣。它们具有再生骨、脂肪和软骨的能力,调节免疫系统,以及滋养其他骨髓造血干细胞/祖细胞的生长和功能,这些特性都已通过 MSCs 的移植应用得到了评估。这些应用需要分离和扩展细胞生产规模。为了研究可用于生物制造过程中生物活性预测的 MSC 的生物物理特性,我们使用低密度接种模型使 MSCs 进入增殖应激状态,并表现出体外衰老的标志性特征。低密度接种方法用于生成第 1-7 代的 MSCs,以模拟这些细胞的连续扩增,从而从单个供体中获得最大产量。同时对 MSCs 进行了三种生物活性测定,以确定 MSC 年龄、大小和形状的变化是否与效力测定的结果相关。研究发现,MSC 的年龄是脂肪生成的预测因子,而细胞和核的形状与造血支持能力密切相关。总之,这些数据评估了与细胞效力相关的形态变化,并强调了用于 MSC 质量评估的新的纯化策略或替代方法。